載入...
Combined pan-RAF and MEK inhibition overcomes multiple resistance mechanisms to selective RAF inhibitors
RAF and MEK inhibitors are effective in BRAF-mutant melanoma but not in BRAF-mutant colorectal cancer. To gain additional insights into this difference, we performed a genome-scale, pooled shRNA enhancer screen in a BRAF-mutant, BRAF-inhibitor resistant colorectal cancer cell line exposed to the sel...
Na minha lista:
| 發表在: | Mol Cancer Ther |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4674359/ https://ncbi.nlm.nih.gov/pubmed/26351322 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-15-0136-T |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|